Mja Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.50 M
as on 06-07-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.40 M
as on 06-07-2024
- Revenue 299.33%
(FY 2022)
- Profit 149.82%
(FY 2022)
- Ebitda 180.07%
(FY 2022)
- Net Worth 196.87%
(FY 2022)
- Total Assets 52.19%
(FY 2022)
About Mja Pharmatech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.40 M.
Janardhana Subramanya, Sundar Devanahalli, and Ashokkumar Murthy serve as directors at the Company.
- CIN/LLPIN
U74999KA2020PTC141610
- Company No.
141610
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mja Pharmatech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Janardhana Subramanya  | Director | 28-Nov-2020 | Current |
| Sundar Devanahalli | Director | 28-Nov-2020 | Current |
| Ashokkumar Murthy | Director | 28-Nov-2020 | Current |
Financial Performance and Corporate Structure Insights of Mja Pharmatech.
Mja Pharmatech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 299.33% increase. The company also saw a substantial improvement in profitability, with a 149.82% increase in profit. The company's net worth Soared by an impressive increase of 196.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mja Pharmatech?
In 2022, Mja Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Jun 2023 | ₹1.70 M | Open |
Hdfc Bank Limited Creation Date: 06 Jun 2023 | ₹1.70 M | Open |
How Many Employees Work at Mja Pharmatech?
Mja Pharmatech has a workforce of 26 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mja Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mja Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
